This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday – ATAI Life Sciences (NASDAQ:ATAI), IonQ (NYSE:IONQ)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Ladenburg Thalmann initiates coverage on Comstock Inc. LODE with a Buy rating and announced a price target of $12. Comstock shares closed at $3.44 on Tuesday. See how other analysts view this stock.
• Oppenheimer analyst Jay Olson initiated coverage on Atai Life Sciences N.V. ATAI with an Outperform rating and announced a price target of $14. ATAI Life Sciences shares closed at $3.31 on Tuesday. See how other analysts view this stock.
• Rosenblatt analyst Kevin Garrigan initiated coverage on IonQ, Inc. IONQ with a Buy rating and announced a price target of $70. IonQ shares closed at $40.53 on Tuesday. See how other analysts view this stock.
• Wolfe Research analyst Peter Supino initiated coverage on Lionsgate Studios Corp. LION with a Peer Perform rating. Lionsgate Studios shares closed at $6.29 on Tuesday. See how other analysts view this stock.
• Bernstein analyst William Pickering initiated coverage on Sarepta Therapeutics, Inc. SRPT with a Market Perform rating and announced a price target of $13. Sarepta Therapeutics shares closed at $15.83 on Tuesday. See how other analysts view this stock.

Considering buying IONQ stock? Here’s what analysts think:

Read This Next:

• Jim Cramer Prefers This Financial Stock Over Brighthouse Financial

Photo via Shutterstock